Tamene Berhanu | Medicine and Health Sciences | Best Researcher Award

Mr. Tamene Berhanu | Medicine and Health Sciences | Best Researcher Award

Wolaita sodo university Ethiopia

Tamene Berhanu Alaho is a dedicated Ethiopian mental health specialist with over a decade of hands-on experience in psychiatric care and psychosocial support. Based in Wolaita Sodo, South Ethiopia, he currently works at Wolaita Sodo University Comprehensive Specialized Hospital (WSUCSH), where he combines clinical practice with student training. Tamene is passionate about holistic mental healthcare, particularly in community-based and crisis settings.

Profile

Scopus

Orcid

🎓 Education

Tamene began his academic journey at Abela Shoyn Primary School (1993–1998 E.C.), then advanced to Humbo Tebela Preparatory and Secondary School (1999–2005 E.C.). He earned his undergraduate degree from Mettu University (2006–2009 E.C.). Driven by his passion for mental health, he pursued his postgraduate studies at Jimma University (2013–2015 E.C.), earning an MSc in Integrated Clinical and Community Mental Health.

💼 Experience

Tamene started his career in September 2010 E.C. at Amanuel Mental Specialized Hospital and AKHC in Addis Ababa, serving as a junior psychiatric professional. From November 2011 to 2013 F.C., he worked at WSUTRH, where he led the psychiatry unit, managing treatments and coordinating patient care. He was a mental health focal person in Wolaita Zone during the COVID-19 crisis, helping patients cope with mental health emergencies. From December 2013 to April 2015 E.C., while studying at Jimma University, he simultaneously provided psychiatric services. Since April 2015 E.C., Tamene has been serving as a mental health specialist at WSUCSH, managing psychiatric cases and training medical students.

🔬 Research Interests

Tamene’s interests include integrated psychiatric care, community mental health, crisis response, and substance use disorder treatment. He focuses on enhancing mental health service accessibility in underserved communities and implementing culturally sensitive psychosocial interventions.

🏆 Awards & Training

Tamene received training in Mental Health and Psychosocial Support (MHPS) in June 2012 E.C. at Hawassa University, strengthening his capacity to respond to psychological needs during crises. He has been recognized within his institutions for his dedicated service, especially during COVID-19-related mental health challenges.

📚 Publications Top Notes: 

Tamene Berhanu Alaho has made scholarly contributions to mental health research. Notably:

“Magnitude of depression and associated factors among patients with tuberculosis attending public health institutions in southern Ethiopia”
📅 Published in 2021 in PLOS ONE
🔗 Read the article here
🔍 Cited by 13 articles

Stefano Stefano | Medicine and Health Sciences | Best Researcher Award

Dr. Stefano Stefano | Medicine and Health Sciences | Best Researcher Award

MD, Specializing in Rheumatology (4th year) University of Bari, Rheumatology Unit Italy

👨‍⚕️ Stefano Stano is a 4th-year MD specializing in Rheumatology at the University of Bari “Aldo Moro,” Polyclinic Hospital. His passion for rheumatology and medical research drives his active involvement in clinical and translational studies, focusing on systemic sclerosis, Sjögren’s disease, and other connective tissue disorders. Stefano aspires to pursue a Ph.D. and build an academic career contributing to advancements in rheumatology.

Profile

Orcid

Education

🎓 Stefano holds an MD and is in the final year of his specialization in Rheumatology at the University of Bari “Aldo Moro.” His academic journey is marked by consistent dedication to both theoretical and practical aspects of his field.

Experience

🩺 With over 5 years of daily involvement in research and clinical practice, Stefano balances laboratory experiments and outpatient assessments. His hands-on approach to rheumatic diseases has honed his skills in addressing complex cases and conducting in-depth studies.

Research Interests

🔬 Stefano’s research is centered on rheumatic diseases, with a special emphasis on systemic sclerosis and Sjögren’s syndrome. He is particularly interested in exploring translational approaches that bridge laboratory findings with clinical applications.

Awards

🏅 Stefano aims to secure the Best Researcher Award in recognition of his efforts in advancing rheumatological research. His dedication and achievements position him as a strong contender.

Publications Top Notes: 

📚 Stefano’s contributions to the field are evidenced by his peer-reviewed publications, which include studies on targeted therapies, systemic sclerosis, and rheumatoid arthritis. His works have been published in reputed journals:

Cacciapaglia F, et al. (2022). Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis. J Pers Med. Read here.

Fornaro M, et al. (2022). Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry. Eur J Clin Invest. Read here.

Cacciapaglia F, et al. (2022). Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review. Journal of Scleroderma and Related Disorders. Read here.

De Luca G, et al. (2024). Rituximab retention rate in systemic sclerosis: a long-term real-life multicenter study. Rheumatology. Read here.

Iannone C, et al. (2024). Pulmonary and extra-pulmonary effects of lung transplantation in systemic sclerosis. Rheumatology. Read here.

De Lorenzis E, et al. (2024). Long-term retention rate, adverse event temporal patterns, and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. Read here.

Fornaro M, et al. (2024). Effectiveness of tapering rituximab dose in idiopathic inflammatory myopathies: Real-world data from a monocentric study. Joint Bone Spine. Read here.

Stano S, et al. (2024). Anti-aquaporin-5 and anti-poly-U-binding-factor-60kDa protein antibodies in primary Sjögren’s disease patients: Preliminary data and correlation with disease activity indices. Clin Exp Rheumatol. Read here.

Cacciapaglia F, et al. (2024). Modulation of IL-6 receptor/STAT3 downstream signaling in rheumatoid arthritis patients. Exp Mol Pathol. Read here.

 

Jan Vorwerk | Medicine and Health Sciences | Young Scientist Award

Dr. Jan Vorwerk | Medicine and Health Sciences | Young Scientist Award

Resident Physician University Cancer Center Schleswig-Holstein (UCCSH) Germany

Dr. Jan Vorwerk is a distinguished medical researcher and clinician currently serving as a resident physician and clinician scientist at the Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), Germany. With a summa cum laude distinction for his medical doctorate and over five years of advanced medical training across Germany, Canada, and Switzerland, Dr. Vorwerk has made remarkable contributions to hematology and oncology research, particularly in acute myeloid leukemia (AML).

Profile

Scopus

Education 🎓

Dr. Vorwerk completed his Medical Doctorate at the University of Münster, with a groundbreaking thesis on the role of GFI1-36N polymorphism in DNA repair and AML therapy, earning summa cum laude honors. He is also a proud alumnus of the University of Zürich and McMaster University. His rigorous academic journey includes first-class grades in multiple state exams and prestigious scholarships from organizations like the German Academic Scholarship Foundation.

Experience 🏥

Dr. Vorwerk’s professional journey includes significant roles as a scholar at the Jürgen Manchot Foundation and the Interdisciplinary Center for Clinical Research Münster. Currently, he is at the forefront of clinical and molecular research in oncology as a resident physician at UCCSH, where he integrates cutting-edge therapies with patient care.

Research Interests 🔬

Dr. Vorwerk specializes in molecular hematology and oncology, focusing on the genetic and metabolic underpinnings of acute myeloid leukemia (AML). His research explores polymorphisms affecting DNA repair, mitochondrial function, and innovative therapeutic targets like CDK4/6 inhibition in leukemia and multiple myeloma.

Awards 🏆

Dr. Vorwerk has been recognized with numerous accolades, including the “Anne Frank Ambassador Award” for academic excellence and community leadership, the “Abitur Graduate Prize” from North Rhine-Westphalia, and scientific honors like the “Young People’s Award” and multiple international science fair prizes.

Publications Top Notes: 📚

Dr. Vorwerk has authored several impactful publications:

Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition. Front Oncol. 2022;12:903691.

Germline single-nucleotide polymorphism GFI1-36N causes alterations in mitochondrial metabolism and leads to increased ROS-mediated DNA damage in AML. Biomedicines. 2025;13:107.

Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to therapy. Blood. 2023;142(25):2175-2191.